Artal S.A. is an investment fund managing more than $3.89 trillion ran by Anne Goffard. There are currently 109 companies in Mrs. Goffard’s portfolio. The largest investments include Cava Group Inc and Lexicon Pharmaceuticals Inc, together worth $2.47 trillion.
As of 7th August 2024, Artal S.A.’s top holding is 23,507,990 shares of Cava Group Inc currently worth over $2.18 trillion and making up 56.0% of the portfolio value.
In addition, the fund holds 175,099,384 shares of Lexicon Pharmaceuticals Inc worth $294 billion, whose value fell 47.9% in the past six months.
The third-largest holding is Scholar Rock Corp worth $93.8 billion and the next is Kymera Therapeutics worth $89.7 billion, with 3,005,610 shares owned.
Currently, Artal S.A.'s portfolio is worth at least $3.89 trillion. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
The Artal S.A. office and employees reside in Luxembourg, Luxembourg. According to the last 13-F report filed with the SEC, Anne Goffard serves as the Authorized Person at Artal S.A..
In the most recent 13F filing, Artal S.A. revealed that it had opened a new position in
Avidity Biosciences and bought 655,555 shares worth $26.8 billion.
This means they effectively own approximately 0.1% of the company.
Avidity Biosciences makes up
2.0%
of the fund's Health Care sector allocation and has grown its share price by 419.7% in the past year.
The investment fund also strengthened its position in Lexicon Pharmaceuticals Inc by buying
57,546,100 additional shares.
This makes their stake in Lexicon Pharmaceuticals Inc total 175,099,384 shares worth $294 billion.
Lexicon Pharmaceuticals Inc soared 1.8% in the past year.
On the other hand, there are companies that Artal S.A. is getting rid of from its portfolio.
Artal S.A. closed its position in Madrigal Pharmaceuticals Inc on 14th August 2024.
It sold the previously owned 110,507 shares for $29.5 billion.
Anne Goffard also disclosed a decreased stake in Cava Group Inc by 0.1%.
This leaves the value of the investment at $2.18 trillion and 23,507,990 shares.
The two most similar investment funds to Artal S.A. are Parallel Advisors and Turtle Creek Asset Management Inc. They manage $3.9 trillion and $3.88 trillion respectively.
Artal S.A.’s portfolio is diversified across 7 sectors.
Currently, their heaviest sector is Health Care — making up 34.3% of
the total portfolio value.
The fund focuses on investments in the United States as
55.0% of the portfolio companies
are based in the United States.
The majority of the companies in the fund’s portfolio are large-cap stocks.
Stocks with a size of more than $10 billion in market cap make up
21% of the total holdings value.
On the other hand, small-cap stocks make up only 5.5% of the portfolio.
The average market cap of the portfolio companies is close to $87.3 billion.
These positions were updated on August 14th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| Cava Group Inc |
11.32%
23,507,990
|
$2,180,366,073,000 | 55.98% |
| Lexicon Pharmaceuticals Inc |
48.95%
175,099,384
|
$294,166,966,000 | 7.55% |
| Scholar Rock Holding Corp |
No change
11,259,438
|
$93,791,119,000 | 2.41% |
| Kymera Therapeutics, Inc. |
0.71%
3,005,610
|
$89,717,459,000 | 2.30% |
| Morphic Holding Inc |
14.13%
2,525,998
|
$86,060,752,000 | 2.21% |
| Arrowhead Pharmaceuticals Inc. |
5.03%
3,189,389
|
$82,892,220,000 | 2.13% |
| Apellis Pharmaceuticals Inc |
11.54%
1,467,080
|
$56,277,189,000 | 1.44% |
| Dyne Therapeutics, Inc. |
0.07%
1,516,960
|
$53,533,518,000 | 1.37% |
| Silence Therapeutics plc |
No change
2,779,619
|
$52,812,761,000 | 1.36% |
| SpringWorks Therapeutics, Inc. |
7.23%
1,313,026
|
$49,461,689,000 | 1.27% |
| Crinetics Pharmaceuticals Inc |
23.33%
1,066,064
|
$47,749,007,000 | 1.23% |
| Merus Nv |
67.08%
760,355
|
$44,990,205,000 | 1.16% |
| BeiGene Ltd |
25.05%
303,369
|
$43,281,655,000 | 1.11% |
| Revolution Medicines Inc |
22.97%
1,015,776
|
$39,422,267,000 | 1.01% |
| Kura Oncology Inc |
5.21%
1,819,884
|
$37,471,412,000 | 0.96% |
| Vera Therapeutics Inc |
81.02%
915,974
|
$33,139,939,000 | 0.85% |
| Madrigal Pharmaceuticals Inc |
Closed
110,507
|
$29,509,789,000 | |
| Neumora Therapeutics Inc |
3.42%
2,824,052
|
$27,760,431,000 | 0.71% |
| Cytokinetics Inc |
2.40%
494,421
|
$26,787,730,000 | 0.69% |
| Avidity Biosciences, Inc. |
Opened
655,555
|
$26,779,422,000 | 0.69% |
| IGM Biosciences, Inc. |
8.12%
3,330,422
|
$22,879,999,000 | 0.59% |
| Wave Life Sciences Ltd. |
12.71%
4,566,251
|
$22,785,592,000 | 0.59% |
| Erasca Inc |
103.99%
9,630,810
|
$22,728,712,000 | 0.58% |
| Tango Therapeutics Inc |
14.81%
2,519,841
|
$21,620,236,000 | 0.56% |
| Viking Therapeutics Inc |
Closed
253,863
|
$20,816,766,000 | |
| Prothena Corporation plc |
No change
1,001,360
|
$20,668,070,000 | 0.53% |
| Centessa Pharmaceuticals Plc |
49.56%
2,112,500
|
$19,075,875,000 | 0.49% |
| Cullinan Therapeutics Inc |
Opened
1,057,949
|
$18,450,631,000 | 0.47% |
| Alpine Immune Sciences Inc |
Closed
405,784
|
$16,085,278,000 | |
| Newamsterdam Pharma Company Nv |
No change
800,000
|
$15,368,000,000 | 0.39% |
| Xenon Pharmaceuticals Inc |
50.58%
381,554
|
$14,876,790,000 | 0.38% |
| Edgewise Therapeutics Inc |
No change
811,718
|
$14,619,041,000 | 0.38% |
| Solid Biosciences Inc |
No change
2,500,000
|
$14,175,000,000 | 0.36% |
| Korro Bio Inc |
1.47%
413,072
|
$13,990,749,000 | 0.36% |
| Ascendis Pharma A/S |
Opened
101,100
|
$13,788,018,000 | 0.35% |
| Agenus Inc |
Opened
775,000
|
$12,981,250,000 | 0.33% |
| Syros Pharmaceuticals Inc. |
No change
2,505,013
|
$12,925,867,000 | 0.33% |
| Astria Therapeutics Inc |
Closed
884,214
|
$12,445,312,000 | |
| Gossamer Bio, Inc. |
No change
13,308,968
|
$11,990,049,000 | 0.31% |
| Amicus Therapeutics Inc |
Closed
1,011,776
|
$11,918,721,000 | |
| Denali Therapeutics Inc |
No change
502,899
|
$11,677,315,000 | 0.30% |
| Ultragenyx Pharmaceutical Inc. |
54.55%
275,000
|
$11,302,500,000 | 0.29% |
| Biohaven Ltd |
Opened
306,703
|
$10,645,661,000 | 0.27% |
| Celldex Therapeutics Inc. |
Closed
253,000
|
$10,618,410,000 | |
| Apogee Therapeutics Inc |
Closed
152,500
|
$10,133,625,000 | |
| Taysha Gene Therapies, Inc. |
18.08%
4,354,214
|
$9,753,439,000 | 0.25% |
| Lexeo Therapeutics Inc |
24.73%
603,435
|
$9,679,097,000 | 0.25% |
| Agenus Inc |
Closed
15,631,235
|
$9,066,116,000 | |
| Acelyrin Inc |
15.98%
2,020,888
|
$8,912,116,000 | 0.23% |
| Janux Therapeutics Inc |
306.00%
203,000
|
$8,503,670,000 | 0.22% |
| Cartesian Therapeutics Inc |
Opened
304,554
|
$8,226,004,000 | 0.21% |
| Rapport Therapeutics Inc |
Opened
350,000
|
$8,141,000,000 | 0.21% |
| Iovance Biotherapeutics Inc |
Opened
1,011,500
|
$8,112,230,000 | 0.21% |
| Generation Bio Co. |
No change
2,830,591
|
$7,982,267,000 | 0.20% |
| Seer, Inc. |
No change
4,750,000
|
$7,980,000,000 | 0.20% |
| Vigil Neuroscience Inc |
0.97%
1,828,691
|
$7,314,764,000 | 0.19% |
| Mind Medicine Mindmed Inc |
Opened
1,007,875
|
$7,266,779,000 | 0.19% |
| Sea Ltd |
58.95%
97,500
|
$6,963,450,000 | 0.18% |
| Structure Therapeutics Inc |
Closed
151,780
|
$6,505,291,000 | |
| Axsome Therapeutics Inc |
Closed
76,837
|
$6,131,593,000 | |
| PDD Holdings Inc |
19.47%
45,500
|
$6,049,225,000 | 0.16% |
| Cartesian Therapeutics Inc |
Closed
9,136,635
|
$5,938,813,000 | |
| NVIDIA Corp |
2,163.16%
43,000
|
$5,312,220,000 | 0.14% |
| Microsoft Corporation |
352.00%
11,300
|
$5,050,535,000 | 0.13% |
| Visa Inc |
660.00%
19,000
|
$4,986,930,000 | 0.13% |
| Black Diamond Therapeutics Inc |
No change
1,046,517
|
$4,876,769,000 | 0.13% |
| Dynatrace Inc |
202.78%
109,000
|
$4,876,660,000 | 0.13% |
| AlloVir, Inc. |
No change
6,597,167
|
$4,771,731,000 | 0.12% |
| Applied Therapeutics, Inc. |
No change
1,009,500
|
$4,714,365,000 | 0.12% |
| Taiwan Semiconductor Manufacturing Co Ltd |
18.75%
26,000
|
$4,519,060,000 | 0.12% |
| Geron Corp. |
Closed
1,281,194
|
$4,227,940,000 | |
| Foghorn Therapeutics Inc. |
No change
720,720
|
$4,144,140,000 | 0.11% |
| Stoke Therapeutics Inc |
Closed
300,000
|
$4,050,000,000 | |
| Datadog Inc |
201.30%
28,925
|
$3,751,283,000 | 0.10% |
| Alto Neuroscience Inc |
No change
350,000
|
$3,741,500,000 | 0.10% |
| Amazon.com Inc. |
60.42%
19,250
|
$3,720,063,000 | 0.10% |
| Fate Therapeutics Inc |
186.56%
1,032,500
|
$3,386,600,000 | 0.09% |
| Hookipa Pharma Inc |
No change
5,666,410
|
$3,353,381,000 | 0.09% |
| Repare Therapeutics Inc. |
Closed
700,000
|
$3,297,000,000 | |
| ADC Therapeutics SA |
Opened
1,018,461
|
$3,218,337,000 | 0.08% |
| KE Holdings Inc. |
18.18%
225,000
|
$3,183,750,000 | 0.08% |
| Regenxbio Inc |
No change
250,000
|
$2,925,000,000 | 0.08% |
| Adagene Inc |
Closed
1,020,000
|
$2,856,000,000 | |
| Omega Therapeutics Inc |
No change
1,323,530
|
$2,739,707,000 | 0.07% |
| Elevation Oncology Inc |
33.05%
1,013,015
|
$2,735,141,000 | 0.07% |
| Kenvue Inc |
Opened
137,000
|
$2,490,660,000 | 0.06% |
| Sagimet Biosciences Inc |
No change
724,771
|
$2,478,717,000 | 0.06% |
| GlycoMimetics Inc |
No change
8,589,064
|
$2,418,680,000 | 0.06% |
| Vor Biopharma Inc |
Closed
1,000,000
|
$2,370,000,000 | |
| Procore Technologies, Inc. |
240.00%
32,300
|
$2,141,813,000 | 0.05% |
| ServiceNow Inc |
Opened
2,500
|
$1,966,675,000 | 0.05% |
| Ovid Therapeutics Inc |
No change
2,500,000
|
$1,923,000,000 | 0.05% |
| Gritstone Bio Inc |
194.00%
3,030,952
|
$1,872,825,000 | 0.05% |
| Pepgen Inc |
43.34%
113,317
|
$1,808,539,000 | 0.05% |
| Apple Inc |
Closed
10,000
|
$1,714,800,000 | |
| Palo Alto Networks Inc |
50.00%
4,500
|
$1,525,545,000 | 0.04% |
| Kyverna Therapeutics Inc |
No change
200,000
|
$1,500,000,000 | 0.04% |
| Qualcomm, Inc. |
Opened
7,500
|
$1,493,850,000 | 0.04% |
| Aerovate Therapeutics Inc |
Opened
809,600
|
$1,343,936,000 | 0.03% |
| Alphabet Inc |
No change
7,000
|
$1,275,050,000 | 0.03% |
| Metagenomi Inc |
No change
300,000
|
$1,224,000,000 | 0.03% |
| Tourmaline Bio Inc |
70.93%
91,426
|
$1,175,738,000 | 0.03% |
| Rubrik Inc |
Opened
35,000
|
$1,073,100,000 | 0.03% |
| Kronos Bio, Inc. |
No change
842,954
|
$1,045,263,000 | 0.03% |
| MongoDB Inc |
101.05%
4,021
|
$1,005,089,000 | 0.03% |
| New Oriental Education & Technology Group Inc. |
16.67%
12,500
|
$971,625,000 | 0.02% |
| Kanzhun Ltd |
Opened
50,000
|
$940,500,000 | 0.02% |
| JFrog Ltd |
Opened
25,000
|
$938,750,000 | 0.02% |
| PayPal Holdings Inc |
50.00%
15,000
|
$870,450,000 | 0.02% |
| Advanced Micro Devices Inc. |
Closed
4,500
|
$812,205,000 | |
| Intel Corp. |
Opened
25,000
|
$774,250,000 | 0.02% |
| Ironwood Pharmaceuticals Inc |
No change
110,532
|
$720,669,000 | 0.02% |
| Pegasystems Inc. |
No change
11,500
|
$696,095,000 | 0.02% |
| Snowflake Inc. |
22.29%
5,051
|
$682,340,000 | 0.02% |
| Achilles Therapeutics Plc |
No change
755,375
|
$615,631,000 | 0.02% |
| Confluent Inc |
No change
19,000
|
$561,070,000 | 0.01% |
| Ccc Intelligent Solutions Holdings Inc |
Opened
50,000
|
$555,500,000 | 0.01% |
| Meta Platforms Inc |
Opened
1,100
|
$554,642,000 | 0.01% |
| Adobe Inc |
70.97%
900
|
$499,986,000 | 0.01% |
| Intapp Inc |
55.93%
13,000
|
$476,710,000 | 0.01% |
| Clearwater Analytics Hldgs I |
Closed
25,000
|
$442,250,000 | |
| Hippo Hldgs Inc |
Closed
24,000
|
$438,480,000 | |
| Tesla Inc |
No change
2,000
|
$395,760,000 | 0.01% |
| Remitly Global Inc |
Opened
25,000
|
$303,000,000 | 0.01% |
| Cyclerion Therapeutics, Inc. |
15.34%
117,643
|
$270,579,000 | 0.01% |
| Caribou Biosciences Inc |
No change
105,347
|
$172,769,000 | 0.00% |
| Dell Technologies Inc |
Opened
1,000
|
$137,910,000 | 0.00% |
| Dlocal Ltd |
65.06%
10,482
|
$84,799,000 | 0.00% |
| Perception Capital Corp Iii |
Opened
126,666
|
$3,547,000 | 0.00% |
| Mink Therapeutics Inc |
Closed
1,916
|
$1,740,000 | |
| No transactions found | |||
| Showing first 500 out of 130 holdings | |||